Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma - Wise-Draper, T M; Gulati, S; Palackdharry, S (Clin Cancer Res, 2022)